Home » Topics » Regulatory » Patents

Patents
RSS

Allelix reports thrombospondin-derived antihemorrhagic peptide

Dec. 11, 1996

New IGF-I variant disclosed by P&U

Dec. 11, 1996

New neurotensin receptor ligands from Sanofi

Dec. 11, 1996

cGMP-PDE inhibitors revealed by Fujisawa

Dec. 11, 1996

HMR describes NK1/NK2 antagonists for respiratory indications

Dec. 11, 1996

Antitumor borneol esters reported by Schering AG

Dec. 11, 1996

LG Chemical describes novel vaccine adjuvant formulation

Dec. 11, 1996

Knoll claims potential anticonvulsants

Dec. 11, 1996

Pharma Mar describes cytotoxic xenicane diterpenes

Dec. 11, 1996

New neuroleptic agents reported by Ferrer

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....